Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2- primary breast cancer. This is an ASCO Meeting Abstract from the 2014 Breast Cancer Symposium. This abstract does not include a full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results